Pharma Research appoints Sohn Ji-hoon as new CEO

Pharma Research said it appointed Sohn Ji-hoon as its new CEO to enhance its global business competitiveness. The company announced on the 21st that Sohn will officially assume his duties in March, leading the company as its sole CEO.

Sohn Ji-hoon, an experienced global business professional, holds a degree in economics from Korea University and an MBA from Boston University. He began his career at the headquarters of multinational pharmaceutical company Bristol-Myers Squibb (BMS) and has since accumulated over 35 years of extensive experience in the pharmaceutical and biotechnology industries.

His previous roles include Executive Director of Global Business at Dong-A Pharmaceutical, GM of Baxter Korea, CEO of Dongwha Pharmaceutical, CEO of Hugel, and most recently CEO of Genuone Science.

Notably, during his tenure as Hugel CEO, Sohn successfully secured approvals for botulinum toxin products in the U.S., Europe, and China, leading the company to consecutive record-high revenues.

“Sohn possesses extensive experience and strategic leadership in both Korean and international pharmaceutical and biotech sectors,” a Pharma Research official said. “He will establish a stable presence in key overseas markets such as the U.S. and Europe, laying the foundation for Pharma Research’s transformation into a global company.”

Meanwhile, Kang Ki-seok, who has led Pharma Research for the past two decades, will transition into a non-executive advisory role to support the company’s sustainable growth.

Related Posts

  • Pharma
  • July 9, 2025
  • 90 views
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The…

  • Pharma
  • July 9, 2025
  • 98 views
Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

That half-empty bottle of painkillers or expired anxiety pills in your drawer could do more harm than good and Apex drug regulatory body, CDSCO, has said it’s best to flush…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

HC-ordered expert panel for weight loss drug may be set up by mid-July

HC-ordered expert panel for weight loss drug may be set up by mid-July